Chinese english Germany Japanese Korea

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72 Struktur
1185309-59-4
CAS-Nr.
1185309-59-4
Englisch Name:
2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72
Synonyma:
2-(piperidin-4-ylamino)pyridine-3-carbonitrile;2-(4-Piperidinylamino)-3-pyridinecarbonitrile hydrochloride;2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72
CBNumber:
CB52593280
Summenformel:
C11H15ClN4
Molgewicht:
238.7166
MOL-Datei:
1185309-59-4.mol
Request For Quotation

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72 Eigenschaften

storage temp. 
Sealed in dry,Room Temperature

Sicherheit

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72 Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 49374 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169109
 market03@meryer.com China 40228 62
Amber MolTech LLC 086-010-62176588
amber@jyamber.com China 10151 56
Wuxi jinluoli Pharmaceutical Technology Co., Ltd. 18021193238
 534936027@qq.com China 363 58
Hebei Beckman Biotechnology Co., Ltd. 15961617865 15961617865
 2245485247@qq.com China 2457 58
  • 2-(Piperidin-4-ylaMino)-nicotinonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72
  • 2-(4-Piperidinylamino)-3-pyridinecarbonitrile hydrochloride
  • 2-(piperidin-4-ylamino)pyridine-3-carbonitrile
  • 1185309-59-4
Copyright 2019 © ChemicalBook. All rights reserved